Cardiology Associations

This page includes news coverage of cardiology societies and associations. Follow these links for specific cardiology society news pages: American College of Cardiology (ACC), American Heart Association (AHA), American Society of Echocardiography (ASE), American Society Nuclear Cardiology (ASNC), European Society of Cardiology (ESC), Heart Rhythm Society (HRS), Society for Cardiovascular Angiography Interventions (SCAI), Society of Cardiovascular Computed Tomography (SCCT), Transcatheter Cardiovascular Therapeutics (TCT), and Vascular Interventional Advances (VIVA).

Chest pain drug lowers risk of kidney injury after PCI
Treating certain high-risk PCI patients with nicorandil before and after treatment can significantly reduce their risk of contrast-related injuries.
New digital platform gets clinicians on the same page when treating heart attacks
One of the platform's biggest benefits is the rich clinical information it provides to all members of the care team.
Sex-specific outcomes after TAVR and SAVR: Key takeaways from a new meta-analysis
TAVR was associated with early benefits for women. After five years, however, outcomes were comparable across the board.
Hundreds of cardiologists incorrectly added to new mandatory payment model
When CMS shared a list of cardiologists being targeted with a brand new payment model, the American College of Cardiology identified a long list of apparent mistakes.
Private equity unlikely to dominate cardiology despite hype
Medaxiom CEO Jerry Blackwell, MD, MBA, FACC, discusses investor's interest in buying cardiology practices, noting that PE ownership remains relatively low.

Kit Crancer, chair of the Radiology Business Management Association Radiology (RBMA) Patient Action Network, and senior vice president of public policy for Rayus, explains RBMA's concerns over how the Trump administration's $1 trillion in cuts to Medicaid will economically impact rural hospitals.

Cardiology groups among the many voices asking Congress not to cut Medicaid

More than 40 U.S. healthcare organizations are urging Congress not to make sweeping Medicaid cuts that could result in approximately 7.6 million Americans losing health insurance.

Video interview with Andreas Ruck, MD, explaining a SWEDHEART registry comparison of Acurate Neo2 to Sapien and Evolut TAVR valves.

Cardiologist highlights safety, effectiveness of Boston Scientific TAVR valve

Andreas Ruck, MD, discussed new registry data on Boston Scientific’s Acurate neo2 TAVR valve, comparing it to popular devices from Edwards Lifesciences and Medtronic.

When valves fail: Surgeons share advice for treating high-risk patients with TAVR explant and SAVR

When a patient’s TAVR valve fails, redo TAVR is not always a feasible option. TAVR explantation and SAVR are typically the answer in these cases, but that approach is associated with certain risks.

Intravascular lithotripsy IVL carotid artery TAVR

A new use for IVL: helping cardiologists secure transcarotid access for TAVR

IVL can do more than help prep patients for PCI. In fact, one heart team used Shockwave Medical's IVL technology to secure access for a high-risk TAVR patient.

Cardiologists are first in world to use new cooling device to terminate AFib during surgery

Patients often develop AFib during cardiac surgery, leading to longer hospital stays, additional healthcare costs and a higher risk of mortality. Cooling the oblique sinus of the patient's heart as soon as AFib starts to develop may represent a new way to stop the problem in its tracks.

Dan Budoff explains use of CCTA to track coronary disease plaque progression

CCTA shows colchicine's impact on atherosclerosis progression

Matthew Budoff, MD, detailed new data highlighting CCTA's value when it comes to tracking the progression of coronary atherosclerosis.

High Lp(a) levels increase risk of repeat cardiovascular events—LDL drugs may help

Researchers evaluated data from more than 273,000 patients with a history of ASCVD, noting that higher Lp(a) levels are consistently linked to worse cardiovascular outcomes.

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

Answering key follow-up questions after the FDA approved TAVR in asymptomatic patients

The approval of certain TAVR valves to be used in asymptomatic patients is expected to make a significant impact on patient care going forward.

Cardiology Associations

Chest pain drug lowers risk of kidney injury after PCI

New digital platform gets clinicians on the same page when treating heart attacks

Sex-specific outcomes after TAVR and SAVR: Key takeaways from a new meta-analysis

Hundreds of cardiologists incorrectly added to new mandatory payment model

Private equity unlikely to dominate cardiology despite hype